Joseph Lubega, MD, MPH, CPE
- Cancer and Blood Disorders
Director, Global Hematology-Oncology Pediatric Excellence (HOPE), Texas Children's Cancer and Hematology Center
Associate Director, East Africa Pediatric Hematology/Oncology Fellowship Training Program
Associate Professor, Department of Pediatrics, Section of Oncology-Hematology, Baylor College of Medicine
Phone:
832-822-4242
Fax:
832-825-1453
Languages: English
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Joseph Lubega, MD, MPH, CPE
Dr. Joseph Lubega is Associate Director of the East Africa Pediatric Hematology/Oncology Fellowship Training Program and Chair of the Pediatric East Africa Clinical Oncology Consortium (PEACOC). He was previously the Medical Director for Global Hematology/Oncology Pediatric Excellence (HOPE) in Uganda.
Led by Dr. Joseph Lubega, the East Africa Pediatric Hematology/Oncology Fellowship Training Program’s initial outcomes resulting from this fellowship are substantial and include improved clinical outcomes for pediatric cancer patients at the Uganda Cancer Institute, including a significant increase in patient response to treatment and reduction in patient deaths.
He is Vice Chair of the Global Special Interest Group (SIG) for the American Society of Pediatric Hematology/Oncology (ASPHO). His responsibilities include organizing the SIG meeting at the annual meeting, engaging members who have an interest in Global pediatric hematology/oncology, and working to grow and extend the reach of ASPHO beyond the United States. He will become Chair at the conclusion of the 2020 annual meeting.
Dr. Lubega was been selected to serve on the U.S. Pharmacopeia Healthcare Safety & Quality Expert Committee from 2020 – 2025 where he focuses on issues relating to appropriateness, safety and access to pharmaceutical products for children in the U.S. and around the world.
Dr. Joseph Lubega received his medical degree from Makerere University in Kampala, Uganda. He trained in Internal Medicine, Surgery, and Pediatrics in the United Kingdom before relocating to the Newark Beth Israel Medical Centre in Newark, New Jersey to complete Residency in Pediatrics. He was recognized as Resident of the Year in Pediatrics in June 2011 at the Newark Beth Israel Medical Center where he was based out of the Children's Hospital of New Jersey. His Fellowship in Pediatric Hematology-Oncology was completed at Baylor College of Medicine, where he was based at Texas Children's Cancer and Hematology Center. He received a Master of Science in Public Health degree in the division of Epidemiology at the University of Texas Health Science Center at Houston, School of Public Health and completed a NCI-sponsored training fellowship in Pediatric Cancer Epidemiology and Control.
He is board certified by the American Board of Pediatrics.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Fellowship | Pediatric Hematology-Oncology | 2014 |
| University of Texas School of Public Health | Masters | Master of Science-Epidemiology | 2014 |
| University of Texas at Houston School of Public Health | Masters | Master of Public Health, Epidemiology | 2014 |
| Newark Beth Israel Medical Center | Residency | Pediatrics | 2011 |
| St. Francis Hospital Nsambya Uganda | Internship | Pediatrics | 2003 |
| Makerere University College of Health Sciences, Kampala Uganda | Medical School | Bachelor of Medicine & Surgery | 2002 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Vice Chair, Global Special Interest Group (SIG) |
Board Certification
American Academy of Pediatrics (AAP)
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Dr. Lubega's research interests focus on the mechanisms of malignant transformation of immune cells by infections (EBV, Herpes Viruses, HIV, Malaria, etc) and other immunological alterations that may result in lymphoma, histiocytosis and possibly leukemia. He is a zealous advocate for building capacity for pediatric cancer care and research in Africa.
